Co-Target(s) Information

Content Navigation (  All   None )                                      
Target General Information
Co-Targets of This Target
References
Target General Information  Top
Target ID T89534 Target Info
Target Name Estrogen receptor (ESR)
Synonyms
Nuclear receptor subfamily 3 group A member 1; NR3A1; Estradiol receptor; ESR; ER-alpha; ER
    Click to Show/Hide
Target Type Successful Target
Gene Name ESR1
Biochemical Class Nuclear hormone receptor
UniProt ID
ESR1_HUMAN
Co-Targets of This Target  Top
Co-Target Name Estrogen receptor beta (ESR2) Successful Target
UniProt ID ESR2_HUMAN
Gene Name ESR2
Synonyms
Oestrogen receptor beta; Nuclear receptor subfamily 3 group A member 2; NR3A2; Erbeta; ESTRB; ER-beta; Beta-1
    Click to Show/Hide
Representative Drug(s) Estradiol Drug Info EC50 = 0.01 nM Click to Show More [1]
2 Diethylstilbestrol Drug Info EC50 = 0.02 nM [2]
3 Estriol Drug Info EC50 = 0.1259 nM [3]
4 Tamoxifen Drug Info Ki = 0.51 nM [6]
5 Fulvestrant Drug Info Ki = 1.39 nM [8]
6 Raloxifene Drug Info IC50 = 1.6 nM [9]
7 Lasofoxifene Drug Info IC50 = 1.8 nM [10]
8 Estrone Drug Info EC50 = 2.1 nM [2]
9 Bazedoxifene Drug Info IC50 = 3.8 nM [13]
10 Ethinyl Estradiol Drug Info IC50 = 8.1 nM [15]
11 ARN-810 Drug Info IC50 = 8.8 nM [16]
12 ARZOXIFENE Drug Info IC50 = 66.3 nM [18]
Co-Target Name Progesterone receptor (PGR) Successful Target
UniProt ID PRGR_HUMAN
Gene Name PGR
Synonyms
PR; Nuclear receptor subfamily 3 group C member 3; NR3C3
    Click to Show/Hide
Representative Drug(s) Fulvestrant Drug Info IC50 = 0.2089 nM Click to Show More [4]
2 AZD9496 Drug Info IC50 = 0.2818 nM [4]
3 Tamoxifen Drug Info IC50 = 128.82 nM [4]
4 ARN-810 Drug Info IC50 ~ 1000 nM [16]
Co-Target Name G-protein coupled estrogen receptor 1 (GPER1) Successful Target
UniProt ID GPER1_HUMAN
Gene Name GPER1
Synonyms
Membrane estrogen receptor; Lymphocyte-derived G-protein coupled receptor; LYGPR; IL8-related receptor DRY12; GPER1; GPER; GPCR-BR; G-protein coupled receptor 30; Flow-induced endothelial G-protein coupled receptor 1; FEG-1; Chemoattractant receptor-like 2
    Click to Show/Hide
Representative Drug(s) Estradiol Drug Info EC50 = 0.3 nM [5]
Co-Target Name Aldehyde oxidase (AOX1) Successful Target
UniProt ID AOXA_HUMAN
Gene Name AOX1
Synonyms
AOX1
    Click to Show/Hide
Representative Drug(s) Raloxifene Drug Info Ki = 0.87 nM Click to Show More [7]
2 Estradiol Drug Info IC50 = 80 nM [20]
3 Ethinyl Estradiol Drug Info Ki = 430 nM [7]
4 Diethylstilbestrol Drug Info IC50 = 460 nM [20]
Co-Target Name Estrogen-related receptor-alpha (ESRRA) Successful Target
UniProt ID ERR1_HUMAN
Gene Name ESRRA
Synonyms
Nuclear receptor subfamily 3 group B member 1; NR3B1; Estrogen-relatedreceptor, alpha; Estrogen-relatedreceptor alpha; Estrogen-related receptor alpha; Estrogen receptor-like 1; ESRL1; ERRalpha; ERR1; ERR-alpha
    Click to Show/Hide
Representative Drug(s) Fulvestrant Drug Info IC50 = 2 nM Click to Show More [11]
2 Estradiol Drug Info IC50 = 3.6 nM [12]
3 Tamoxifen Drug Info IC50 = 200 nM [11]
Co-Target Name Opioid receptor sigma 1 (OPRS1) Successful Target
UniProt ID SGMR1_HUMAN
Gene Name SIGMAR1
Synonyms
hSigmaR1; Sigma1R; Sigma1-receptor; Sigma non-opioid intracellular receptor 1; Sigma 1-type opioid receptor; SRBP; SR31747-binding protein; SR31747 binding protein 1; SR-BP; SIG-1R; Opioid receptor, sigma 1, isoform 1; OPRS1 protein; Aging-associated gene 8 protein; AAG8
    Click to Show/Hide
Representative Drug(s) Clomifene Drug Info Ki = 8 nM Click to Show More [14]
2 Tamoxifen Drug Info Ki = 35 nM [14]
3 Raloxifene Drug Info Ki = 38 nM [14]
Co-Target Name Androgen receptor (AR) Successful Target
UniProt ID ANDR_HUMAN
Gene Name AR
Synonyms
Testosterone receptor; Nuclear receptor subfamily 3 group C member 4; NR3C4; Dihydrotestosterone receptor; DHTR
    Click to Show/Hide
Representative Drug(s) Estradiol Drug Info IC50 = 19.1 nM [17]
Co-Target Name 5-HT 2B receptor (HTR2B) Successful Target
UniProt ID 5HT2B_HUMAN
Gene Name HTR2B
Synonyms
Serotonin receptor 2B; 5-hydroxytryptamine receptor 2B; 5-HT2B; 5-HT-2B; 5-HT 2B
    Click to Show/Hide
Representative Drug(s) Raloxifene Drug Info Ki = 69 nM [19]
Co-Target Name Multidrug resistance protein 1 (ABCB1) Clinical trial Target
UniProt ID MDR1_HUMAN
Gene Name ABCB1
Synonyms
PGY1; P-glycoprotein 1; MDR1; CD243 antigen; CD243; ATP-binding cassette sub-family B member 1
    Click to Show/Hide
Representative Drug(s) Tamoxifen Drug Info Ki = 100 nM [21]
Co-Target Name Farnesoid X-activated receptor (FXR) Successful Target
UniProt ID NR1H4_HUMAN
Gene Name NR1H4
Synonyms
Retinoid X receptor-interacting protein 14; RXR-interacting protein 14; RIP14; Nuclear receptor subfamily 1 group H member 4; HRR1; Farnesol receptor HRR-1; FXR; Bile acid receptor; BAR
    Click to Show/Hide
Representative Drug(s) Fulvestrant Drug Info IC50 = 790 nM [22]
Co-Target Name Glucocorticoid receptor (NR3C1) Successful Target
UniProt ID GCR_HUMAN
Gene Name NR3C1
Synonyms
Nuclear receptor subfamily 3 group C member 1; GRL; GR
    Click to Show/Hide
Representative Drug(s) ARN-810 Drug Info IC50 = 990 nM [16]
Co-Target Name Mineralocorticoid receptor (MR) Successful Target
UniProt ID MCR_HUMAN
Gene Name NR3C2
Synonyms
Nuclear receptor subfamily 3 group C member 2; Mineralocorticoid receptor; MLR; MCR; Inner ear mineralocorticoid receptor; Delta
    Click to Show/Hide
Representative Drug(s) ARN-810 Drug Info IC50 ~ 1000 nM [16]
Co-Target Name Cholestenol delta-isomerase (EBP) Clinical trial Target
UniProt ID EBP_HUMAN
Gene Name EBP
Synonyms
Emopamilbinding protein; EBP; Delta(8)Delta(7) sterol isomerase; D8D7 sterol isomerase; 3betahydroxysteroidDelta(8),Delta(7)isomerase
    Click to Show/Hide
Representative Drug(s) Raloxifene Drug Info Ki = 1 nM Click to Show More [14]
2 Clomifene Drug Info Ki = 1 nM [14]
3 Tamoxifen Drug Info Ki = 5 nM [14]
Co-Target Name Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) Clinical trial Target
UniProt ID DHB1_HUMAN
Gene Name HSD17B1
Synonyms
Short chain dehydrogenase/reductase family 28C member 1; SDR28C1; Placental 17-beta-hydroxysteroid dehydrogenase; Estradiol 17-beta-dehydrogenase 1; EDHB17; EDH17B2; EDH17B1; E2DH; E17KSR; 20-alpha-HSD; 20 alpha-hydroxysteroid dehydrogenase; 17-beta-Hydroxysteroid dehydrogenase type 1; 17-beta-HSD 1
    Click to Show/Hide
Representative Drug(s) Estrone Drug Info Ki = 3 nM [23]
Co-Target Name Soluble epoxide hydrolase (EPHX2) Clinical trial Target
UniProt ID HYES_HUMAN
Gene Name EPHX2
Synonyms
Bifunctional epoxide hydrolase 2
    Click to Show/Hide
Representative Drug(s) Fulvestrant Drug Info IC50 = 6 nM [24]
Co-Target Name Albendazole monooxygenase (CYP3A4) Clinical trial Target
UniProt ID CP3A4_HUMAN
Gene Name CYP3A4
Synonyms
Taurochenodeoxycholate 6-alpha-hydroxylase; Quinine 3-monooxygenase; P450-PCN1; Nifedipine oxidase; NF-25; HLp; Cytochrome P450-PCN1; Cytochrome P450 NF-25; Cytochrome P450 HLp; Cytochrome P450 3A4; Cytochrome P450 3A3; CYPIIIA4; CYPIIIA3; CYP3A3; Albendazole sulfoxidase; Albendazole monooxygenase (sulfoxide-forming); 1,8-cineole 2-exo-monooxygenase
    Click to Show/Hide
Representative Drug(s) Tamoxifen Drug Info Ki = 200 nM [25]
Co-Target Name 5-HT 6 receptor (HTR6) Clinical trial Target
UniProt ID 5HT6R_HUMAN
Gene Name HTR6
Synonyms
Serotonin receptor 6; 5-hydroxytryptamine receptor 6; 5-HT6 receptor; 5-HT6; 5-HT-6
    Click to Show/Hide
Representative Drug(s) Raloxifene Drug Info Ki = 750 nM [26]
Co-Target Name Protein kinase C (PRKC) Clinical trial Target
UniProt ID KPCA_HUMAN; KPCB_HUMAN; KPCD1_HUMAN; KPCD3_HUMAN; KPCD_HUMAN; KPCE_HUMAN; KPCG_HUMAN; KPCI_HUMAN; KPCL_HUMAN; KPCT_HUMAN; KPCZ_HUMAN
Gene Name NO-GeName
Representative Drug(s) Tamoxifen Drug Info IC50 = 1000 nM [27]
Co-Target Name Estrogen-related receptor-beta (ESRRB) Literature-reported Target
UniProt ID ERR2_HUMAN
Gene Name ESRRB
Synonyms
Steroid hormone receptor ERR2; Nuclear receptor subfamily 3 group B member 2; NR3B2; Estrogen-related receptor beta; Estrogen receptor-like 2; ESRL2; ERRB2; ERR-beta; ERR beta-2
    Click to Show/Hide
Representative Drug(s) Estradiol Drug Info IC50 = 3.2 nM [12]
Co-Target Name Estrogen-related receptor-gamma (ESRRG) Literature-reported Target
UniProt ID ERR3_HUMAN
Gene Name ESRRG
Synonyms
Nuclear receptor subfamily 3 group B member 3; NR3B3; KIAA0832; Estrogen-related receptor gamma; Estrogen receptor-related protein 3; ERRG2; ERR3; ERR gamma-2
    Click to Show/Hide
Representative Drug(s) Tamoxifen Drug Info IC50 = 62.2 nM Click to Show More [28]
2 Diethylstilbestrol Drug Info EC50 = 630 nM [29]
Co-Target Name Cytochrome P450 2B6 (CYP2B6) Literature-reported Target
UniProt ID CP2B6_HUMAN
Gene Name CYP2B6
Synonyms
Cytochrome P450 IIB1; CYPIIB6; 1,4-cineole 2-exo-monooxygenase
    Click to Show/Hide
Representative Drug(s) Ethinyl Estradiol Drug Info Ki = 800 nM Click to Show More [25]
2 Tamoxifen Drug Info Ki = 900 nM [25]
Co-Target Name Emopamil-binding protein-like (EBPL) Co-Target
UniProt ID EBPL_HUMAN
Gene Name EBPL
Synonyms
Emopamil-binding-related protein
    Click to Show/Hide
Representative Drug(s) Tamoxifen Drug Info Ki = 2.8 nM [30]
Co-Target Name Sulfotransferase 1A1 (SULT1A1) Co-Target
UniProt ID ST1A1_HUMAN
Gene Name SULT1A1
Synonyms
Aryl sulfotransferase 1; Phenol-sulfating phenol sulfotransferase 1; P-PST 1; ST1A1; HAST1/HAST2; Phenol sulfotransferase 1; ST1A3; Thermostable phenol sulfotransferase; Ts-PST
    Click to Show/Hide
Representative Drug(s) Ethinyl Estradiol Drug Info Ki = 8.9 nM [31]
Co-Target Name Cytochrome P450 2J2 (CYP2J2) Co-Target
UniProt ID CP2J2_HUMAN
Gene Name CYP2J2
Synonyms
Albendazole monooxygenase (hydroxylating); Albendazole monooxygenase (sulfoxide-forming); Arachidonic acid epoxygenase; Hydroperoxy icosatetraenoate isomerase; CYPIIJ2
    Click to Show/Hide
Representative Drug(s) Danazol Drug Info IC50 = 12 nM [32]
Co-Target Name Sex hormone-binding globulin (SHBG) Co-Target
UniProt ID SHBG_HUMAN
Gene Name SHBG
Synonyms
SHBG; Sex steroid-binding protein; SBP; Testis-specific androgen-binding protein; ABP; Testosterone-estradiol-binding globulin; TeBG; Testosterone-estrogen-binding globulin
    Click to Show/Hide
Representative Drug(s) Estradiol Drug Info IC50 = 50 nM [33]
Co-Target Name Cytochrome P450 2C8 (CYP2C8) Co-Target
UniProt ID CP2C8_HUMAN
Gene Name CYP2C8
Synonyms
CYPIIC8; Cytochrome P450 IIC2; Cytochrome P450 MP-12; Cytochrome P450 MP-20; Cytochrome P450 form 1; S-mephenytoin 4-hydroxylase
    Click to Show/Hide
Representative Drug(s) ARN-810 Drug Info IC50 < 100 nM [16]
References  Top
REF 1 Influence of chlorine or fluorine substitution on the estrogenic properties of 1-alkyl-2,3,5-tris(4-hydroxyphenyl)-1H-pyrroles. J Med Chem. 2012 Nov 26;55(22):9607-18.
REF 2 Toward selective ERbeta agonists for central nervous system disorders: synthesis and characterization of aryl benzthiophenes. J Med Chem. 2002 Mar 28;45(7):1399-401.
REF 3 The A-CD analogue of 16beta,17alpha-estriol is a potent and highly selective estrogen receptor beta agonist. Medchemcomm. 2013;4:1439-42.
REF 4 Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist. J Med Chem. 2015 Oct 22;58(20):8128-40.
REF 5 Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol. 2006 Apr;2(4):207-12.
REF 6 Hydrophobic Interactions Improve Selectivity to ERalpha for Ben-zothiophene SERMs. ACS Med Chem Lett. 2012 Mar 8;3(3):207-10.
REF 7 Evidence for substrate-dependent inhibition profiles for human liver aldehyde oxidase. Drug Metab Dispos. 2013 Jan;41(1):24-9.
REF 8 De novo design, synthesis, and evaluation of novel nonsteroidal phenanthrene ligands for the estrogen receptor. J Med Chem. 2003 Apr 10;46(8):1408-18.
REF 9 Benzothieno[3,2-b]indole derivatives as potent selective estrogen receptor modulators. Bioorg Med Chem Lett. 2005 Jun 2;15(11):2891-3.
REF 10 Estrogen receptor ligands. Part 11: Synthesis and activity of isochromans and isothiochromans. Bioorg Med Chem Lett. 2005 Feb 1;15(3):715-8.
REF 11 Synthesis of novel estrogen receptor antagonists using metal-catalyzed coupling reactions and characterization of their biological activity. J Med Chem. 2013 Apr 11;56(7):2779-90.
REF 12 ERbeta ligands. Part 6: 6H-Chromeno[4,3-b]quinolines as a new series of estrogen receptor beta-selective ligands. Bioorg Med Chem Lett. 2007 Jul 15;17(14):4053-6.
REF 13 Estrogen receptor ligands. Part 14: application of novel antagonist side chains to existing platforms. Bioorg Med Chem Lett. 2005 Dec 1;15(23):5124-8.
REF 14 Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening. J Med Chem. 2005 Jul 28;48(15):4754-64.
REF 15 Novel chromene-derived selective estrogen receptor modulators useful for alleviating hot flushes and vaginal dryness. J Med Chem. 2006 Jun 1;49(11):3056-9.
REF 16 Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts. J Med Chem.2015 Jun 25;58(12):4888-904.
REF 17 Androstenediol analogs as ER-beta-selective SERMs. Bioorg Med Chem Lett. 2006 Feb 15;16(4):834-8.
REF 18 Benzothiophene selective estrogen receptor modulators with modulated oxidative activity and receptor affinity. J Med Chem. 2007 May 31;50(11):2682-92.
REF 19 Development, validation, and use of quantitative structure-activity relationship models of 5-hydroxytryptamine (2B) receptor ligands to identify no... J Med Chem. 2010 Nov 11;53(21):7573-86.
REF 20 Aldehyde oxidase: an enzyme of emerging importance in drug discovery. J Med Chem. 2010 Dec 23;53(24):8441-60.
REF 21 Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis). J Med Chem. 2002 Dec 19;45(26):5671-86.
REF 22 Development of time resolved fluorescence resonance energy transfer-based assay for FXR antagonist discovery. Bioorg Med Chem. 2013 Jul 15;21(14):4266-78.
REF 23 Design and synthesis of bisubstrate inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: overview and perspectives. Eur J Med Chem. 2008 Nov;43(11):2298-306.
REF 24 Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides. Bioorg Med Chem Lett. 2013 Jul 1;23(13):3818-21.
REF 25 Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity. Curr Drug Metab. 2005 Oct;6(5):413-54.
REF 26 Chemocentric informatics approach to drug discovery: identification and experimental validation of selective estrogen receptor modulators as ligands of 5-hydroxytryptamine-6 receptors and as potential cognition enhancers. J Med Chem. 2012 Jun 28;55(12):5704-19.
REF 27 Design and synthesis of triarylacrylonitrile analogues of tamoxifen with improved binding selectivity to protein kinase C. Bioorg Med Chem. 2016 Nov 1;24(21):5495-504.
REF 28 Design and synthesis of benzoacridines as estrogenic and anti-estrogenic agents. Bioorg Med Chem. 2017 Oct 15;25(20):5216-37.
REF 29 Identification and structure-activity relationship of phenolic acyl hydrazones as selective agonists for the estrogen-related orphan nuclear receptors ERRbeta and ERRgamma. J Med Chem. 2005 May 5;48(9):3107-9.
REF 30 Synthesis and biological evaluation of ??F labeled fluoro-oligo-ethoxylated 4-benzylpiperazine derivatives for sigma-1 receptor imaging. Bioorg Med Chem. 2013 Jan 1;21(1):215-22.
REF 31 Potent inhibition of human sulfotransferase 1A1 by 17alpha-ethinylestradiol: role of 3'-phosphoadenosine 5'-phosphosulfate binding and structural rearrangements in regulating inhibition and activity. Drug Metab Dispos. 2012 Aug;40(8):1588-95.
REF 32 Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity. Drug Metab Dispos. 2012 May;40(5):943-51.
REF 33 Progressive docking: a hybrid QSAR/docking approach for accelerating in silico high throughput screening. J Med Chem. 2006 Dec 14;49(25):7466-78.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.